LEI: 549300Q7EXQQH6KF7Z84
16 May 2024
RTW BIOTECH OPPORTUNITIES
LTD
(the "Company")
Results of the Annual General
Meeting ("AGM")
The Company is pleased to announce
that, at the fifth AGM held at 14.00 BST today, 16 May 2024,
each of the Resolutions was duly passed without
amendment.
The details of each resolution are
as follows:
ORDINARY RESOLUTIONS
Resolution 1
IT
WAS RESOLVED to receive and
consider the Audited Financial Statements, the Directors' report,
and the auditor's report for the financial year ended 31
December 2023.
|
For
|
155,157,923 votes
|
|
Against
|
6,187 votes
|
|
Withheld
|
2,000,475 votes
|
Resolution 2
IT
WAS RESOLVED to approve the
Directors' remuneration for the financial year ended 31
December 2023 as provided in the Directors' report.
|
For
|
155,070,793 votes
|
|
Against
|
75,328 votes
|
|
Withheld
|
2,018,464 votes
|
Resolution 31
IT
WAS RESOLVED to re-elect
William Simpson as a Director of the Company.
|
For
|
539,838,649 votes
|
|
Against
|
13,270 votes
|
|
Withheld
|
1,999,179 votes
|
Resolution 41
IT
WAS RESOLVED to re-elect Paul
Le Page as a Director of the Company.
|
For
|
539,837,024 votes
|
|
Against
|
14,895 votes
|
|
Withheld
|
1,999,179 votes
|
Resolution 51
IT
WAS RESOLVED to re-elect Bill
Scott as a Director of the Company.
|
For
|
539,837,024 votes
|
|
Against
|
14,895 votes
|
|
Withheld
|
1,999,179 votes
|
Resolution 6
IT
WAS RESOLVED to re-elect
Stephanie Sirota as a Director of the Company.
|
For
|
153,047,444 votes
|
|
Against
|
2,117,962 votes
|
|
Withheld
|
1,999,179 votes
|
Resolution 7
IT
WAS RESOLVED to
re-appoint KPMG Channel Islands Limited and KPMG
LLP as Auditor of the Company.
|
For
|
155,134,937 votes
|
|
Against
|
29,173 votes
|
|
Withheld
|
2,000,475 votes
|
Resolution 8
IT
WAS RESOLVED to authorise the
Board of Directors to determine the remuneration of the
Auditor.
|
For
|
155,151,289 votes
|
|
Against
|
13,729 votes
|
|
Withheld
|
1,999,567 votes
|
As
Special business
|
Resolution 9
IT
WAS RESOLVED That the Company be and is hereby authorised, in accordance
with section 315 of the Companies (Guernsey) Law, 2008, as amended
(the "Companies Law"), subject to the Listing Rules made by
the United Kingdom Financial Conduct Authority and all
other applicable legislation and regulations, to make market
acquisitions (within the meaning of section 316 of the Companies
Law) of its own Ordinary Shares (as defined in the Company's
Articles) which may be cancelled or held as treasury shares,
provided that:
i. the
maximum number of Ordinary Shares authorised to be purchased under
this authority shall be 57,844,388 Ordinary Shares (being 14.99 per
cent. of the Ordinary Shares in issue as at the Latest Practicable
Date, excluding any treasury shares);
ii. the
minimum price (exclusive of expenses) which may be paid for an
Ordinary Share is US$0.01;
iii. the maximum
price (exclusive of expenses) which may be paid for an Ordinary
Share shall be not more than an amount equal to the higher of (a) 5
per cent. above the average mid-market value of the Ordinary Shares
on the regulated market where the repurchase is carried out for the
five Business Days (as defined in the Company's Articles) prior to
the day the purchase is made and (b) the higher of (i) the price of
the last independent trade and (ii) the highest current independent
bid price, in each case on the regulated market where the purchase
is carried out; and
such authority to expire on
the date which is 15 months from the date of passing of this
resolution or, if earlier, at the end of the Annual General Meeting
of the Company to be held in 2025 (unless previously renewed,
revoked or varied by the Company by ordinary resolution), save that
the Company may make a contract to acquire Ordinary Shares under
this authority before its expiry which will or may be executed
wholly or partly after its expiration and the Company may make
an acquisition of Ordinary Shares pursuant to such a
contract.
|
|
|
For
|
157,097,103 votes
|
|
Against
|
46,656 votes
|
|
Withheld
|
20,826 votes
|
|
|
Resolution 10
IT
WAS RESOLVED That the Company be and
is hereby authorised, in accordance with the Company's Articles and
the Companies Law, to redeem the 48,322,863 Ordinary Shares in the
Company currently held by RTW Biotech Opportunities Operating Ltd,
for nil consideration.
|
For
|
157,029,750 votes
|
|
Against
|
66,953 votes
|
|
Withheld
|
67,882 votes
|
|
|
Responses to investors' questions
will be posted on the Company's website after the AGM.
¹ The
Company notes that the voting rights adjustments under Article 6
and Article 23 of the Company's Articles of Incorporation were used
in respect of resolutions 3, 4, and 5, but this did not affect the
outcome of the shareholder vote.
|
*A vote withheld is not a vote in
law and is therefore not counted towards the proportion of votes
"for" or "against" the Resolution.
For
Further Information
|
RTW
Investments, LP
|
+44
(0)20 7959 6361
|
|
Woody Stileman, Managing
Director
Krisha McCune, Director,
IR
|
|
|
biotechopportunities@rtwfunds.com
|
|
|
|
|
|
Buchanan Communications
|
+44
(0)20 7466 5107
|
|
Charles Ryland
|
|
|
Henry Wilson
|
|
|
Numis
|
+44
20 7260 1000
|
|
Freddie Barnfield
|
|
|
Nathan Brown
|
|
|
Euan Brown
|
|
|
|
|
|
BofA Securities
|
+44
20 7628 1000
|
|
Edward Peel
|
|
|
Alex Penney
|
|
|
|
|
|
Cadarn Capital
David Harris
|
+44
73 6888 3211
|
About
Biotech Opportunities Ltd:
RTW Biotech Opportunities Ltd (LSE:
RTW & RTWG) is an investment fund focused on identifying
transformative assets with high growth potential across the
biopharmaceutical and medical technology sectors. Driven by a
long-term approach to support innovative businesses, RTW Biotech
Opportunities Ltd invests in companies developing next-generation
therapies and technologies that can significantly improve patients'
lives. RTW Biotech Opportunities Ltd is managed by RTW Investments,
LP, a leading healthcare-focused
entrepreneurial investment firm with
deep scientific expertise and a strong track record of supporting
companies developing life-changing therapies.
Visit the website
at www.rtwfunds.com/rtw-biotech-opportunities-ltd for
more information.